article thumbnail

We Need Better Benchmarks for Machine Learning in Drug Discovery

Practical Cheminformatics

It is quite a bit more potent than the values one finds with screening hits, which typically have IC50s in the single to double-digit µM range. Many have suggested that pharmaceutical companies should open more of their data to the community. 200nM is an odd choice for an activity cutoff.

Drugs 84